Filing
Spy
Filing
Spy
Home
About
AXSM
Axsome Therapeutics Inc
Biopharmaceutical company developing CNS therapies
CUSIP: 05464T104
Healthcare
US
1 holder
Ownership
Activity
2025 Q1
3 of 3 quarters
Total Value
$4.99M
Total Shares
42.8K
Net Share Change
+42.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$4.99M
42.8K
0.0%
NEW
Bridgewater Associates LP
$4.99M
42.8K shares
NEW
AXSM — Axsome Therapeutics Inc - FilingSpy